Risk factors for prognosis after the Maze IV procedure in patients with atrial fibrillation undergoing valve surgery

heart model
Credit: Unsplash/CC0 Public Domain

In a new publication from Cardiovascular Innovations and Applications, Hui Yang, Pu Zou, Yuhu He and colleagues from Central South University, Changsha, Hunan, China discuss risk factors for prognosis after the Maze IV procedure in patients with atrial fibrillation undergoing valve surgery.

The authors of this article evaluated related to persistent (AF) at discharge (AF-d) and recurrent atrial fibrillation (rAF) and all-cause death after the Maze IV procedure. Two hundred nineteen patients (63 female, aged 52.5±8.8 years) with and persistent AF undergoing valve surgery and the IV procedure between 2015 and 2016 were included. Baseline demographic and were obtained by review of medical records. The median follow-up period was 27 months (interquartile range 21–34 months) in the patient cohort. The primary end point was all-cause death. The secondary end point was AF-d or rAF. rAF is defined as AF recurrence at three months or later after the procedure.

Twenty-eight patients (12.8%) died during follow-up. Multiple logistic regression analysis showed that thrombocytopenia, elevated serum total bilirubin level, a larger right atrium, AF-d, and rAF were independent determinants for all-cause death after the Maze IV procedure after adjustment for age, sex, and clinical covariates, including New York Heart Association class III/IV disease, hypertension, and aortic regurgitation, while valvular disease duration and left atrial diameter greater than 80.5 mm were independent determinants for AF-d, and thrombocytopenia, elevated serum total bilirubin level, higher mean pulmonary artery pressure, and AF-d were independent predictors for rAF.

The authors conclude that thrombocytopenia, elevated serum total bilirubin level, an enlarged right atrium, AF-d, and rAF are independent predictors of all-cause death in patients undergoing the Maze IV procedure.


Explore further

Cardiac CTA parameters predict post-transcatheter aortic valve replacement mortality

More information: Shenghua Zhou, Risk Factors for Prognosis after the Maze IV Procedure in Patients with Atrial Fibrillation Undergoing Valve Surgery, Cardiovascular Innovations and Applications (2021). DOI: 10.15212/CVIA.2021.0026
Provided by Compuscript Ltd
Citation: Risk factors for prognosis after the Maze IV procedure in patients with atrial fibrillation undergoing valve surgery (2021, October 27) retrieved 25 January 2022 from https://medicalxpress.com/news/2021-10-factors-prognosis-maze-iv-procedure.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
2 shares

Feedback to editors